Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful cardiac ...

Please provide your email address to receive an email when new articles are posted on . Abnormal ECG findings were rare in elite female basketball players. These data may serve as a reference for ...

Even minor ECG abnormalities detected with annual checks signal a greater risk of future CVD events, a study of several million working-age people affirms, although questions remain about whether ...

The electrocardiogram built into recent Apple Watch models isn’t likely to give wearers false notifications that they have atrial fibrillation, a potentially dangerous heart condition. A clean bill of ...

The electrocardiogram test commonly given to people suspected of having cramping chest pains from angina have limited value when it comes to predicting future heart problems, a new study suggests.

AccurKardia, an innovator in ECG-based diagnostics technology, today announced results from a new study demonstrating that its AI-enabled ECG technology, AK-AVS™, can detect aortic stenosis years ...

HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful ...